Molina Healthcare Investors Face Dec. 2 Lead‑Plaintiff Deadline in Securities Suit

Overview

• Notices from Rosen, Schall, and DJS invite purchasers of Molina securities from February 5 to July 23, 2025 to contact the firms.
• A filed complaint alleges nondisclosure of adverse medical cost trend assumptions and a dislocation between premium rates and actual costs.
• The allegations include that 2025 financial guidance was likely to be cut due to higher utilization in behavioral health, pharmacy, and inpatient and outpatient services.
• The case asserts violations of Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b‑5.
• No class has been certified, so investors are not represented unless they retain counsel, and serving as lead plaintiff is not required to share in any potential recovery.